FY26 Lab Consolidation for Coagulation CPRR Effort
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY HCD WEST
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT941026Q2004
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6550
Additional Details
The Defense Health Agency (DHA), under the Department of Defense, has issued a combined synopsis/solicitation (Solicitation Number HT941026Q2004) for the FY26 Lab Consolidation for Coagulation Cost Per Reportable Result (CPRR) Effort. This procurement seeks to establish a contract for the provision of coagulation analyzers and associated services to support military treatment facilities (MTFs) across the United States. The intent is to consolidate laboratory capabilities, streamline operations, and ensure consistent, high-quality coagulation testing within the military healthcare system.
The scope of this requirement encompasses the supply, installation, and ongoing support of analytical laboratory instruments specifically designed for coagulation testing. The contract will be structured on a cost per reportable result basis, meaning the contractor will be compensated according to the number of valid test results delivered. This approach is intended to optimize cost efficiency while maintaining rigorous standards for diagnostic accuracy and reliability. The list of participating MTFs and their specific workload requirements are detailed within the solicitation documents.
Key objectives of the procurement include:
- Provision of state-of-the-art coagulation analyzers capable of meeting the diverse testing needs of multiple MTFs.
- Implementation of a comprehensive transition plan to ensure seamless integration of new equipment and processes, as reflected in the updated Statement of Work (SOW).
- Delivery of all required instruments, reagents, consumables, and technical support necessary for uninterrupted laboratory operations.
- Adherence to all applicable federal acquisition regulations and DHA-specific requirements.
The solicitation has undergone several amendments to clarify requirements, update submission deadlines, and incorporate feedback from potential offerors. Notably, the most recent amendments have revised the SOW to include a transition plan deliverable, adjusted anticipated delivery start dates, and updated pricing and technical submission forms. Contractors are advised to review all attachments and amendments carefully to ensure compliance with the latest requirements.
This opportunity is classified under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing), with a size standard of 1,000 employees, and Product Service Code 6550 (In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets). The procurement is unrestricted, inviting full and open competition; it is not set aside for small business concerns.
The place of performance is within the United States, supporting various DHA-affiliated MTFs. The contracting activity is managed by the Defense Health Agency HCD West office. Interested contractors should direct inquiries and submissions to the designated points of contact: Bobbie Dobberstein ([email protected], 478-919-4484) and Cha-On Gordon ([email protected], 726-203-0109).
All solicitation documents, including the Statement of Work, technical submission forms, and quote sheets, are available via the official SAM.gov posting (Opportunity ID: 6c3ef79c02944d1f97be7406571f4216). Contractors are responsible for reviewing all provisions and clauses incorporated by reference, as well as ensuring timely submission of quotations and any required feedback.
This procurement represents a significant opportunity for qualified vendors specializing in laboratory instrumentation and diagnostic solutions to support the critical mission of military healthcare. Contractors with proven capabilities in delivering, integrating, and supporting advanced coagulation testing platforms are encouraged to review the solicitation in detail and consider submitting a proposal.
Documents14